Legacy App users can now access the Health Portal – just reset your password using email as username.

Can Equipoise Replace Primobolan During Shortages? (TRT Q&As)

Can Equipoise Replace Primobolan During Shortages? (TRT Q&As)

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Timeline

Timestamp
Topic
00:00
Can Equipoise substitute for Primobolan during shortages?

Equipoise can be a powerful muscle-building androgen, but Dr. O’Connor emphasizes that it can also substantially increase red blood cell production and erythrocytosis risk.
09:30
Should I stop testosterone before a total knee replacement?

Dr. O’Connor does not automatically recommend stopping TRT but stresses individualized assessment of venous thromboembolism risk and appropriate postoperative clot prevention with the surgical and medical team.
16:44
Can injectable Proviron be used to control estrogen while taking testosterone?

Dr. O’Connor explains that Proviron should not be viewed as a systemic aromatase inhibitor and believes its anti-estrogenic effects are more likely occurring at specific tissues rather than substantially lowering circulating estradiol.
34:33
Why did I develop panic attacks and anxiety after nine months on TRT?

Testosterone can worsen anxiety or other psychiatric symptoms in a susceptible minority of men, and Dr. O’Connor recommends reassessing the original indication, dose, mental health history, and individual response rather than using a cookie-cutter TRT approach.
42:43
Should I inject testosterone enanthate more often when switching from testosterone cypionate?

Dr. O’Connor says the two esters have similar pharmacokinetics and recommends choosing a practical schedule, maintaining it long enough to reach steady state, and judging the response from symptoms and properly timed laboratory testing.
52:48
Can I add Primobolan if my estimated GFR is 58?

An eGFR below 60 deserves further evaluation before assuming true kidney disease because muscle mass and creatine can affect creatinine-based estimates, and Dr. O’Connor recommends confirming kidney function before adding more androgen exposure.

Video Summary

This Q&A opens with whether Equipoise can substitute for Primobolan when supply shortages limit access. Dr. O’Connor explains that Equipoise can be a powerful muscle-building androgen but also strongly stimulates red blood cell production, making erythrocytosis and broader cardiovascular risk important concerns.

The discussion moves through several testosterone and anabolic-steroid questions, including whether TRT should be stopped before major joint replacement surgery, the risk of DVT and pulmonary embolism, whether Proviron can control estrogen, and how testosterone, Equipoise, Trenbolone, Primobolan, and Masteron differ in their effects.

Later questions address panic and anxiety after TRT, switching between testosterone cypionate and enanthate, injection frequency, low SHBG, and whether additional Primobolan is appropriate when estimated kidney function is reduced. Throughout the Q&A, Dr. O’Connor repeatedly emphasizes individualized assessment, blood pressure, cardiovascular and kidney health, laboratory interpretation, and avoiding unnecessary androgen exposure.

Drug Callouts

Drug
Description
Testosterone
Testosterone appears throughout the Q&A in discussions of TRT dosing, surgery, anxiety, injection frequency, estrogen effects, and combination steroid use. Dr. O’Connor repeatedly emphasizes individualized dosing and monitoring rather than assuming more testosterone or additional androgens will improve outcomes.
Equipoise (Boldenone)
Equipoise is discussed as a possible substitute for Primobolan during supply shortages and as part of classic testosterone-based steroid combinations. Dr. O’Connor emphasizes its strong muscle-building effects while warning that it can markedly increase red blood cell production.
Primobolan
Primobolan is discussed in relation to shortages, estrogen-related observations, combination androgen use, and whether it should be added when kidney function may already be impaired. Dr. O’Connor repeatedly cautions against assuming that a comparatively mild anabolic steroid is automatically safe.
Proviron
Proviron is discussed as a DHT-derived androgen with tissue-level anti-estrogenic properties. Dr. O’Connor does not consider it a systemic aromatase inhibitor and questions using underground injectable versions for estrogen control.
Xarelto (Rivaroxaban)
Xarelto is discussed as one option for postoperative anticoagulation in patients at meaningful risk for venous thromboembolism. Dr. O’Connor emphasizes that anticoagulation around major orthopedic surgery requires individualized medical supervision rather than self-treatment.
Eliquis (Apixaban)
Eliquis is discussed alongside Xarelto as a modern anticoagulant used for clot prevention in selected surgical patients. Dr. O’Connor stresses evaluating the individual patient’s DVT and pulmonary embolism risk before deciding on prophylaxis.

Condition Callouts

Condition
Description
Androgen-Induced Erythrocytosis
Equipoise and other androgens can substantially increase red blood cell production in men already using testosterone. Dr. O’Connor repeatedly emphasizes monitoring hemoglobin, hematocrit, iron status, and the complete cardiovascular risk profile rather than focusing on androgen benefits alone.
Deep Vein Thrombosis
DVT is a major concern around knee or hip replacement because surgery, tissue trauma, inflammation, reduced mobility, and individual clotting risks can combine to produce a venous thromboembolic event. Men using testosterone require individualized perioperative risk assessment rather than assuming TRT itself is the only factor.
Pulmonary Embolism
Dr. O’Connor describes his own postoperative pulmonary embolism to illustrate how a clot originating after major orthopedic surgery can travel to the lungs and become life-threatening. Testosterone users undergoing surgery should have their complete clotting risk assessed by the treating physicians.
Anxiety And Panic Attacks
One viewer reports severe panic attacks and anxiety after months on TRT. Dr. O’Connor explains that testosterone may worsen underlying psychiatric vulnerability in some men and recommends individualized assessment rather than assuming every patient will respond positively to TRT.
Chronic Kidney Disease
An eGFR of 58 raises concern for possible chronic kidney disease before adding more anabolic steroid exposure. Dr. O’Connor emphasizes confirming whether kidney function is truly impaired because muscular men and creatine users can have misleading creatinine-based estimates.

Key Takeaways

  • Equipoise may substitute for Primobolan in some steroid regimens, but its strong effect on red blood cell production increases health concerns.
  • Men on TRT undergoing major orthopedic surgery need individualized clot-risk assessment rather than automatically stopping testosterone or self-prescribing anticoagulants.
  • Proviron should not be treated as a systemic aromatase inhibitor because its anti-estrogenic effects appear to differ from drugs that directly block aromatase.
  • Testosterone can worsen anxiety or panic symptoms in susceptible men, making psychiatric history and individual response important parts of TRT management.
  • Testosterone cypionate and enanthate have similar long-acting pharmacokinetics, so injection frequency should be practical, consistent, and evaluated after steady state.
  • Reduced estimated kidney function should be confirmed carefully before adding Primobolan or other anabolic steroids to an existing testosterone regimen.

More Videos